The Potential of Stem Cells in the Treatment of Skeletal Muscle Injury and Disease

Figure 1

Cell surface epitope characterisation of passage 2 infrapatellar fat-pad-derived stem cells using a panel of antibodies. Cell surface staining using FITC-conjugated secondary antibody (green) and DAPI (blue) shows that the cells stain strongly for CD13, 29, 44, 90, and 105, and poorly for 3G5, LNGFR, STRO-1, and CD34 and 56. No staining was observed for the IgG control. The staining pattern is confirmed by flow cytometry and shows the increase in fluorescence (green) compared with the autofluorescence (black) [21].

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)